Page last updated: 2024-09-03

3-iodo-n(6)-4-aminobenzyladenosine and Obesity

3-iodo-n(6)-4-aminobenzyladenosine has been researched along with Obesity in 1 studies

*Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berkich, DA; LaNoue, KF; Linden, J; Luthin, DR; Vannucci, SJ; Woodard, RL1

Other Studies

1 other study(ies) available for 3-iodo-n(6)-4-aminobenzyladenosine and Obesity

ArticleYear
Evidence for regulated coupling of A1 adenosine receptors by phosphorylation in Zucker rats.
    The American journal of physiology, 1995, Volume: 268, Issue:4 Pt 1

    Topics: Adenosine; Adenylyl Cyclases; Adipocytes; Animals; Cell Membrane; Colforsin; Cyclic AMP; Guanine Nucleotides; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Iodine Radioisotopes; Iodobenzenes; Obesity; Phosphorylation; Proteins; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Purinergic P1

1995